Fair Value Measurements and Investments (Tables)

6 Months Ended

Mar. 31, 2022

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

Assets and Liabilities Measured at Fair Value on a Recurring Basis


	Fair Value Measurements Using Inputs Considered as
	Level 1				Level 2
	March 31, 2022		September 30, 2021		March 31, 2022		September 30, 2021
	(in millions)
Assets
Cash equivalents and restricted cash equivalents:
Money market funds	$	9,448	$	11,779	$	—	$	—
U.S. government-sponsored debt securities	—		—		418		100
U.S. Treasury securities	200		2,400		—		—
Investment securities:
Marketable equity securities	363		490		—		—
U.S. government-sponsored debt securities	—		—		110		245
U.S. Treasury securities	3,043		2,985		—		—
Other current and non-current assets:
Money market funds	4		4		—		—
Derivative instruments	—		—		465		410
Total	$	13,058	$	17,658	$	993	$	755
Liabilities
Accrued compensation and benefits:
Deferred compensation liability	$	179	$	167	$	—	$	—
Accrued and other liabilities:
Derivative instruments	—		—		226		109
Total	$	179	$	167	$	226	$	109

Schedule of Non-Marketable Equity Securities

The following table summarizes the total carrying value of the Company’s non-marketable equity securities held as of March 31, 2022 including cumulative unrealized gains and losses:


	March 31, 2022
	(in millions)
Initial cost basis	$	908
Adjustments:
Upward adjustments	806
Downward adjustments (including impairment)	(66)
Carrying amount, end of period	$	1,648

Unrealized gains and losses included in the carrying value of the Company’s non-marketable equity securities still held as of March 31, 2022 and 2021 were as follows:


	Three Months Ended March 31,				Six Months Ended March 31,
	2022		2021		2022		2021
	(in millions)
Upward adjustments	$	2	$	129	$	226	$	143
Downward adjustments (including impairment)	$	(53)	$	—	$	(53)	$	(2)